These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35195476)

  • 1. Serum concentrations of gabapentin in cats with chronic kidney disease.
    Quimby JM; Lorbach SK; Saffire A; Kennedy A; Wittenburg LA; Aarnes TK; Creighton KJ; Jones SE; Paschall RE; King EM; Bruner CE; Wallinger JN; van Haaften KA
    J Feline Med Surg; 2022 Dec; 24(12):1260-1266. PubMed ID: 35195476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the effect of gabapentin on blood pressure in cats with and without chronic kidney disease.
    Quimby JM; Jones SE; Saffire A; Brusach KK; Kurdziel K; George Z; Paschall RE; Aarnes TK
    J Feline Med Surg; 2024 May; 26(5):1098612X241240326. PubMed ID: 38770706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of serum concentrations of symmetric dimethylarginine and creatinine as kidney function biomarkers in cats with chronic kidney disease.
    Hall JA; Yerramilli M; Obare E; Yerramilli M; Jewell DE
    J Vet Intern Med; 2014; 28(6):1676-83. PubMed ID: 25231385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic use of maropitant for the management of vomiting and inappetence in cats with chronic kidney disease: a blinded, placebo-controlled clinical trial.
    Quimby JM; Brock WT; Moses K; Bolotin D; Patricelli K
    J Feline Med Surg; 2015 Aug; 17(8):692-7. PubMed ID: 25336450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of low-dose meloxicam in cats with chronic kidney disease.
    KuKanich K; George C; Roush JK; Sharp S; Farace G; Yerramilli M; Peterson S; Grauer GF
    J Feline Med Surg; 2021 Feb; 23(2):138-148. PubMed ID: 32594827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary evaluation of fecal fatty acid concentrations in cats with chronic kidney disease and correlation with indoxyl sulfate and p-cresol sulfate.
    Summers S; Quimby JM; Phillips RK; Stockman J; Isaiah A; Lidbury JA; Steiner JM; Suchodolski J
    J Vet Intern Med; 2020 Jan; 34(1):206-215. PubMed ID: 31693251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of serum symmetric dimethylarginine and creatinine concentrations in hyperthyroid cats before and after a fixed dose of orally administered radioiodine.
    Yu L; Lacorcia L; Finch S; Johnstone T
    J Vet Intern Med; 2020 Jul; 34(4):1423-1431. PubMed ID: 32506701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fecal microbiome and serum concentrations of indoxyl sulfate and p-cresol sulfate in cats with chronic kidney disease.
    Summers SC; Quimby JM; Isaiah A; Suchodolski JS; Lunghofer PJ; Gustafson DL
    J Vet Intern Med; 2019 Mar; 33(2):662-669. PubMed ID: 30561098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of mirtazapine in cats with chronic kidney disease and in age-matched control cats.
    Quimby JM; Gustafson DL; Lunn KF
    J Vet Intern Med; 2011; 25(5):985-9. PubMed ID: 21985134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renoprotective effects of docosahexaenoic acid in cats with early chronic kidney disease due to polycystic kidney disease: a pilot study.
    Kobayashi S; Kawarasaki M; Aono A; Cho J; Hashimoto T; Sato R
    J Feline Med Surg; 2022 Dec; 24(12):e505-e512. PubMed ID: 36383208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum fibroblast growth factor-23 concentrations in young and mature adult cats with chronic kidney disease.
    Miyakawa H; Hsu HH; Ogawa M; Akabane R; Miyagawa Y; Takemura N
    J Feline Med Surg; 2022 Aug; 24(8):815-820. PubMed ID: 34431737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of symmetric dimethylarginine in cats with acute kidney injury and chronic kidney disease.
    Loane SC; Thomson JM; Williams TL; McCallum KE
    J Vet Intern Med; 2022 Sep; 36(5):1669-1676. PubMed ID: 35903963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics of gabapentin in cats.
    Adrian D; Papich MG; Baynes R; Stafford E; Lascelles BDX
    J Vet Intern Med; 2018 Nov; 32(6):1996-2002. PubMed ID: 30307652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between serum fibroblast growth factor-23 concentrations and blood calcium levels in chronic kidney disease cats with upper urolithiasis.
    Miyakawa H; Hsu HH; Ogawa M; Akabane R; Miyagawa Y; Takemura N
    J Feline Med Surg; 2022 Dec; 24(12):1245-1252. PubMed ID: 35133180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary F
    Whitehouse W; Quimby J; Wan S; Monaghan K; Robbins R; Trepanier LA
    J Vet Intern Med; 2017 Mar; 31(2):449-456. PubMed ID: 28160524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum concentrations of symmetric dimethylarginine and creatinine in cats with kidney stones.
    Hall JA; Yerramilli M; Obare E; Li J; Yerramilli M; Jewell DE
    PLoS One; 2017; 12(4):e0174854. PubMed ID: 28384169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of compounded transdermal mirtazapine as an appetite stimulant in cats with chronic kidney disease.
    Quimby JM; Benson KK; Summers SC; Saffire A; Herndon AK; Bai S; Gustafson DL
    J Feline Med Surg; 2020 Apr; 22(4):376-383. PubMed ID: 31161850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of serum creatinine, point-of-care symmetric dimethylarginine and renal imaging with glomerular filtration rate measured by renal scintigraphy in healthy and early chronic kidney diseased cats.
    da Cruz Schaefer G; de Mattos Brose M; Herrera Becerra JR; Bernhardt Rovaris I; Peixoto da Silva Mello F; Schneck Simão B; de Faria Valle S; Poletto Ferreira M; Vieira Amorim da Costa F
    Vet Res Commun; 2023 Dec; 47(4):1845-1859. PubMed ID: 37133704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between ultrasonographically determined renal dimensions and International Renal Interest Society stages in cats with chronic kidney disease.
    Yan GY; Chen KY; Wang HC; Ma TY; Chen KS
    J Vet Intern Med; 2020 Jul; 34(4):1464-1475. PubMed ID: 32585054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum fibroblast growth factor 23 (FGF-23): associations with hyperphosphatemia and clinical staging of feline chronic kidney disease.
    Lin J; Lin L; Chen S; Yu L; Chen S; Xia Z
    J Vet Diagn Invest; 2021 Mar; 33(2):288-293. PubMed ID: 33543676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.